clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03615508 |
P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
P17 | country | United States of America | Q30 |
P582 | end time | 2019-08-01 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 10 | |
P4844 | research intervention | oxymetazoline | Q417813 |
phenylephrine | Q421910 | ||
P6153 | research site | Denver Health Medical Center | Q3023367 |
P580 | start time | 2018-09-21 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Exploration of Pupil Dilation in Horner's Patients Taking Flomax |
Search more.